Recent News
Corporate Governance
Stock Information
Financial Information
SEC Filings
Event Calendar
Audio Archive
Shareholder Center
Annual Reports
Email Alerts
Investor FAQs
Investor Contact
Investor Disclaimer
Share
Gilead Sciences Announces Data for Genotype 1 Null Responder Hepatitis C Patients Enrolled in ELECTRON Study - Conference Call
Friday, February 17, 2012
8:00 a.m. ET
Webcast Presentation
Click here for webcast
Title
Gilead Sciences Announces Data for Genotype 1 Null Responder Hepatitis C Patients Enrolled in ELECTRON Study - Conference Call
Date and Time
Friday, February 17, 2012
8:00 a.m. ET
Unauthorized recording or downloading of this event is not permitted.
© Copyright 2009 Thomson Reuters . All rights reserved.
NASDAQ
(US Dollar)
$55.74
0.56
(0.99%)
Data as of 05/20/13 4:00 p.m. ET
Minimum 20 minute delay
Refresh Quote
Webcast Replay
Gilead Sciences Announces Data for Genotype 1 Null Responder Hepatitis C Patients Enrolled in ELECTRON Study - Conference Call
February 17, 2012 8:00 a.m. ET
Play
Gilead Sciences Announces Data for Genotype 1 Null Responder Hepatitis C Patients Enrolled in ELECTRON Study - Conference Call
February 17, 2012 8:00 a.m. ET
Play
2012 Annual Report
2012 Form 10-K
Financial Tear Sheet
Get help downloading or viewing the above file types